InsiderTrades

Form 4 for BSX Boston Scientific

Accepted 2024-02-16 00:00:00 ET · period of report 2024-02-14 · accession 0001225208-24-002308 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-02-16 2024-02-14 BSX Sorenson John Bradley EVP, Gbl Ops F - Tax $65.95 -965 48.5K -2% -$63.6K
D 2024-02-16 2024-02-14 BSX Sorenson John Bradley EVP, Gbl Ops M - OptEx $0.00 +2,115 49.5K +4% $0
D 2024-02-16 2024-02-14 BSX Sorenson John Bradley EVP, Gbl Ops M - OptEx $0.00 -2,115 6,345 -25% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-02-14 F D 965 $65.95 48,486 D — —
2 Common Common Stock 2024-02-14 M A 2,115 $0.00 49,451 D — — (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
3 Derivative Restricted Stock Units 2024-02-14 M D 2,115 $0.00 6,345 D — · — to 2027-02-14 2,115 Common Stock (F1) Each restricted stock unit represents the Company's commitment to issue one share of Boston Scientific common stock. (F2) Shares of common stock will be issued to the reporting person in four equal annual installments beginning on February 14, 2024, the first anniversary of the date of grant.